Skip to main content

Epoch Secures Patent Protection for MGB Technology

NEW YORK, Feb. 4 (GenomeWeb News) - Epoch Biosciences today said it has been granted a US patent related to the Minor Grove Binder (MGB) technology that underlies its MGB Eclipse Probe genetic analysis system. 

The patent - number 6,683,173, entitled "Tm (DNA Hybridization) Leveling Methods" - covers the use of modified oligonucleotides in designing probes and primers that work in the narrow temperature range used in genetic analysis systems. According to Epoch, "this development greatly improves the performance of hybridization-based systems for genetic analysis," including SNP detection and gene expression analysis.

The MGB technology is used in Epoch's MGB Eclipse Probe Systems, as well as Applied Biosystems' MGB-TaqMan products and BioControl System's food-testing products.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.